Sakiris Spiro Kevin Officer Transaction

On March 18, 2026, Spiro Kevin Sakiris, Chief Financial Officer of Intelligent Bio Solutions Inc., was granted 9,150 restricted shares of Common Stock under the 2019 Long Term Incentive Plan. These shares are subject to time-based vesting over 48 months and are forfeitable until vested. Additionally, on the same date, Sakiris was granted 21,350 restricted shares of Common Stock under the 2019 Plan, subject to both performance-based and time-based vesting requirements and forfeiture. These awarded shares are presented on a post-reverse stock split basis, following a 1-for-10 reverse stock split effected on December 15, 2025. Prior to these grants, Sakiris held 1,911 shares of Common Stock indirectly through Anest Holdings Pty Ltd, as trustee of ATF S&T Sakiris Superannuation Fund.